Johnson Investment Counsel »

Cytosorbents shares owned by Johnson Investment Counsel

Quarter-by-quarter ownership of Cytosorbents (CTSO) shares owned by Johnson Investment Counsel from 13F filings

Historical chart of Johnson Investment Counsel investment in Cytosorbents

Tip: Access up to 7 years of quarterly data

All positions including Cytosorbents held by Johnson Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytosorbents by Johnson Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 20k 1.11

More positions owned by Johnson Investment Counsel

Ishares Core S&p 500 Etf Ef (IVV)
Apple CS (AAPL)
Procter And Gamble CS (PG)
Ishares Russell 1000 Etf Ef (IWB)
Microsoft Corp CS (MSFT)
Alphabet CS (GOOGL)
Ishares Russell Midcap Etf Ef (IWR)
Cincinnati Financial Corp CS (CINF)
Unitedhealth Group CS (UNH)
Mastercard Incorporated CS (MA)
Danaher Corporation CS (DHR)
Accenture Plc Ireland CS (ACN)
Nasdaq CS (NDAQ)
Williams Cos CS (WMB)
Zoetis CS (ZTS)

View all positions for Johnson Investment Counsel

Top funds holding Cytosorbents

Avenir Corporation
Skylands Capital
Vanguard Group
Neuberger Berman Group
Sargent Investment Group
CM Management
Advisor Group Holdings
Bank of America Corporation
Raymond James Financial Services Advisors
Dimensional Fund Advisors
Raymond James & Associates
Millennium Management
Stifel Financial
Key Client Fiduciary Advisors
Chicago Partners Investment

View all funds holding Cytosorbents